Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
November 10, 2025
 · 
Be the first to react
MyLymphomaTeam

Is watch and wait common for DLBCL after therapy if the tumor is only slightly smaller?

Watch and wait is typically not the standard approach for DLBCL after treatment shows only partial response. DLBCL is an aggressive, high-grade lymphoma, and oncologists generally aim for complete remission (CR) where all signs of cancer Show Full Answer

Is watch and wait common for DLBCL after therapy if the tumor is only slightly smaller?

Watch and wait is typically not the standard approach for DLBCL after treatment shows only partial response. DLBCL is an aggressive, high-grade lymphoma, and oncologists generally aim for complete remission (CR) where all signs of cancer disappear.

If your tumor has only gotten slightly smaller after therapy, this would likely be considered a partial response. About 20 percent of people achieve only partial response to first-line R-CHOP treatment, and their DLBCL becomes resistant to that treatment. This is known as primary refractory disease.

In this situation, doctors typically don't recommend watch and wait. Instead, they usually suggest second-line treatment options to try to achieve complete remission. These might include different medications, bone marrow transplant, CAR T-cell therapy, or enrollment in clinical trials.

Watch and wait is more commonly used for slow-growing (indolent) lymphomas like follicular lymphoma, not aggressive types like DLBCL. It's important to discuss your specific situation with your oncologist to understand the best treatment path forward.

November 10, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Nienhagen, DE

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In